Raymond James Trust’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,948
Closed -$325K 1343
2024
Q2
$325K Buy
10,948
+63
+0.6% +$1.75K 0.01% 938
2024
Q1
$328K Buy
10,885
+1,245
+13% +$34.5K 0.01% 925
2023
Q4
$276K Sell
9,640
-1,163
-11% -$34.2K 0.01% 970
2023
Q3
$400K Sell
10,803
-1,228
-10% -$46.9K 0.01% 735
2023
Q2
$470K Sell
12,031
-483
-4% -$18.9K 0.01% 691
2023
Q1
$457K Buy
12,514
+1,234
+11% +$39K 0.01% 666
2022
Q4
$348K Buy
+11,280
New +$350K 0.01% 765

Other funds holding RTO

Raymond James Trust's RTO Position: Q3 2024 in Review

Raymond James Trust sold out of Rentokil (RTO) in Q3 2024, closing a stake of 10,948 shares — an estimated $325K sold.

Raymond James Trust first reported a position in RTO in Q4 2022 and held it in 7 quarters. The position peaked at $470K in Q2 2023. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

  • Raymond James Trust reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
  • Raymond James Trust sold 10,948 Rentokil shares in Q3 2024, an estimated $325K.
  • Raymond James Trust first reported a position in Rentokil in Q4 2022 and held it in 7 quarters.
  • Raymond James Trust's Rentokil position peaked at $470K in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.